Roche Reveals Cholesterol Drug Has Completed Successful Phase II Trial

by Kathy Jones on  August 30, 2011 at 7:03 PM Clinical Trials News
RSS Email Print This Page Comment bookmark
Font : A-A+

Swiss drug manufacturer Roche said that its experimental drug for cholesterol has successfully passed the Phase II trial and revealed that it did not increase blood pressure among its users.
 Roche Reveals Cholesterol Drug Has Completed Successful Phase II Trial
Roche Reveals Cholesterol Drug Has Completed Successful Phase II Trial

The results mean that Roche has successfully overcome the problem that sank Pfizer's cholesterol drug, torcetrapib, which was found to drastically increase the blood pressure.

Roche also revealed that their drug, known as dalcetrapib, increased the level of HDL, or good cholesterol, by more than 31 percent.

Announcing the results, lead investigator Thomas Luescher revealed that while dalcetrapib was not as effective in increasing HDL levels as torcetrapib, it could be an advantage for the drug. "I think we can say it is safe and has no untoward effects and it does the job as far as the lipid (cholesterol) profile is concerned", he said.



Source: Medindia

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Cholesterol High Cholesterol Drug Toxicity Heart Attack Diet Lifestyle and Heart Disease Body Mass Index Signature Drug Toxicity Cholesterol - The Enigma Chemical Liposuction Heart Attack- Lifestyle Risks 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Stay Connected

  • Available on the Android Market
  • Available on the App Store

News Category

News Archive

Loading...